E. Dijke
YOU?
Author Swipe
Multiplex bead immunoassay in ABO-A2-incompatible kidney transplantation Open
Kidney transplantation from ABO-A2 donors into ABO-O and ABO-B recipients can alleviate inequitable transplant access created by ABO demographics. ABO-A2-incompatible (ABO-A2i) eligibility is determined by anti-A hemagglutination titers. H…
First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant Open
Due to their suppressive capacity, regulatory T cells (Tregs) have attracted growing interest as an adoptive cellular therapy for the prevention of allograft rejection, but limited Treg recovery and lower quality of adult-derived Tregs cou…
POS-686 USE OF BORTEZOMIB IN TREATMENT OF KIDNEY TRANSPLANT SUB-CLINICAL ANTIBODY MEDIATED REJECTION Open
Subclinical antibody-mediated rejection is defined as the presence of circulating donor HLA specific antibodies with the presence of typical pathological finding of antibody-mediated rejection and no change in graft function. It is known t…